Barriers and Challenges in Performing Pharmacokinetic Studies to Inform Dosing in the Neonatal Population
A number of barriers and challenges must be overcome in order to conduct the pharmacokinetic studies that are urgently needed to inform the selection and dosing of medication in neonates. However, overcoming these barriers can be difficult. This review outlines the common barriers researchers are co...
Main Authors: | Kate O’Hara, Jennifer H Martin, Jennifer J Schneider |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/8/1/16 |
Similar Items
-
Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants
by: Yang Zhao, et al.
Published: (2020-02-01) -
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates
by: Anne Smits, et al.
Published: (2020-05-01) -
Pharmacokinetics of cephalosporins in the neonate: a review
by: Gian Maria Pacifici
Published: (2011-01-01) -
What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
by: Martin Šíma, et al.
Published: (2021-02-01) -
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017-02-01)